What Is Retatrutide Peptide? A Complete Guide for 2025

Retatrutide (code name: LY-3437943) is a novel investigational peptide designed as a triple agonist targeting the GLP-1, GIP, and glucagon receptors. Developed by Eli Lilly, Retatrutide is currently in Phase 3 clinical trials and has gained significa...